Don't take light of the note in the update that states that the equity cost of raising funds needed for the expansion will determine how quickly things will happen. This is a giant blazing sign to the crooks to continue going after the stock price in earnest.

I am surprised by how open the Company is being about their strategy for expansion -- I assume its either to quell investor inquiries and/or its a reflection of the Company's confidence in expected demand for its products, particularly the N-Assay. The interest during and after the recent conference during which the N-Assay work was presented must've been mind blowing.